GnRHa, aromatase inhibitors, progesterone, and ulipristal acetate may be a choice for treatment.[23,24] Combined with our case, the patient was diagnosed with low-grade malignant leiomyosarcoma and she refused another operation to remove her ovaries. The gene discussed is CYP19A1; the disease is leiomyosarcoma.